HSS Study Evaluates Non-Opioid Pain Relief Following Orthopedic Surgery

The medication, suzetrigine (JOURNAVX (R) ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.

HSS Studies Contribute Early Evidence to Help Guide Emerging Perioperative Considerations for Patients Using GLP--1 Medications

At this year's American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting, researchers at Hospital for Special Surgery (HSS) presented two studies focused on glucagon-like peptide ...

HSS Presents New Research Leveraging AI to Uncover Insights Related to Pain Risk and Anesthesia Education at ASRA Annual Meeting

At this year’s American Society of Regional Anesthesia and Acute Pain Medicine (ASRA) annual meeting, investigators at ...
Business Wire

HSS Researchers Report Benefits of Robotic-Assisted Spine Surgery for Adolescent Athletes with Back Pain Due to Pars Fractures

DENVER--(BUSINESS WIRE)--Spine surgeons at Hospital for Special Surgery (HSS) reported promising findings for adolescent athletes suffering from pars fracture, a common cause of adolescent back pain ...
Becker's ASC

HSS launches national orthopedic ASC platform

New York City-based Hospital for Special Surgery, the nation’s top-ranked orthopedic hospital, is partnering with global growth investor General Atlantic to launch a new, independently operated ...

HSS Appoints Valarie McPherson as Vice President, Ambulatory Operations and Clinical Services

Hospital for Special Surgery (HSS), the world’s leading academic medical center focused on musculoskeletal health, today ...
Business Wire

HSS Announces New Chief of Endocrinology Division and Metabolic Bone Service

NEW YORK--(BUSINESS WIRE)--Hospital for Special Surgery (HSS), the world's leading academic medical center specialized in musculoskeletal health, today announced the appointment of Matthew T. Drake, ...
MM&M

How HSS is empowering patients to choose specialized orthopedic care

In the bustling New York City landscape — where choices are as diverse as the people who live there — the Hospital for Special Surgery (HSS) is inviting patients to rethink their healthcare decisions.
Morningstar

HSS Opens Kellen Tower, Completing Major Upper East Side Campus Expansion

Hospital for Special Surgery (HSS), the world’s leading academic medical center dedicated to musculoskeletal health, today announced the opening of Kellen Tower, a new 94,000-square-foot, 12-story ...
Becker's Hospital Review

HSS reports $94.7M profit for 1st 6 months

New York City-based Hospital for Special Surgery, one of the most renowned orthopedic care hospitals worldwide, reported net income of $94.7 million for the first half of the year. Such a profit on ...
Becker's Hospital Review

HSS expands outpatient presence on Long Island

New York City-based Hospital for Special Surgery is expanding its presence on Long Island with the leasing of a large facility for outpatient services, according to a March 16 Long Island Business ...